|Articles|March 1, 2002
ALA / PDT therapy branches toward benign skin tumors
New Orleans - With a brief yet successful track record of treatingmalignant and pre-malignant skin conditions, 5-aminolevulinic acid (ALA)in combination with photodynamic therapy (PDT) could soon become an effectivealternative for benign cutaneous tumors such as sebaceous hyperplasia, seborrheickeratoses, and plantar warts.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
3
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
4
Journal Digest: January 14, 2026
5














